PR Newswire (press release) If you take TRADJENTA with another medicine that can cause low blood sugar, such as sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea or insulin may need to be lowered while you take TRADJENTA. and more »
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ... and more »
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ...
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ...
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ...
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ...
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ...
Gastroenterology & Endoscopy News Invokana has been studied as a stand-alone therapy and in combination with other therapies for type 2 diabetes, including metformin, sulfonylurea , pioglitazone and insulin. Invokana should not be used to treat people with type 1 diabetes; those who ...
News-Medical.net But the Japanese group found that the EPAC2A deficient mice (EPAC2A knockout mice) did not respond well to sulfonylurea class of drugs, which are used to help ß-cells from diabetic patients to secrete insulin. When ß-cells fail, diabetics benefit from ...
Healio PHOENIX — An SGLT2 inhibitor recently approved by the FDA may improve measures of beta cell function in addition to glycemic control in patients already taking metformin plus sulfonylurea , according to phase 3 study results presented here at the AACE ...
